These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25716795)

  • 1. Bypass of genetic constraints during mutator evolution to antibiotic resistance.
    Couce A; Rodríguez-Rojas A; Blázquez J
    Proc Biol Sci; 2015 Apr; 282(1804):20142698. PubMed ID: 25716795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictable properties of fitness landscapes induced by adaptational tradeoffs.
    Das SG; Direito SO; Waclaw B; Allen RJ; Krug J
    Elife; 2020 May; 9():. PubMed ID: 32423531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fitness of Beta-Lactamase Mutants Depends Nonlinearly on Resistance Level at Sublethal Antibiotic Concentrations.
    Farr AD; Pesce D; Das SG; Zwart MP; de Visser JAGM
    mBio; 2023 Jun; 14(3):e0009823. PubMed ID: 37129484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mistranslation can promote the exploration of alternative evolutionary trajectories in enzyme evolution.
    Zheng J; Bratulic S; Lischer HEL; Wagner A
    J Evol Biol; 2021 Aug; 34(8):1302-1315. PubMed ID: 34145657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial mutations direct alternative pathways of protein evolution.
    Salverda ML; Dellus E; Gorter FA; Debets AJ; van der Oost J; Hoekstra RF; Tawfik DS; de Visser JA
    PLoS Genet; 2011 Mar; 7(3):e1001321. PubMed ID: 21408208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation accumulation and fitness in mutator subpopulations of Escherichia coli.
    Maharjan RP; Liu B; Li Y; Reeves PR; Wang L; Ferenci T
    Biol Lett; 2013 Feb; 9(1):20120961. PubMed ID: 23221876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Darwinian evolution can follow only very few mutational paths to fitter proteins.
    Weinreich DM; Delaney NF; Depristo MA; Hartl DL
    Science; 2006 Apr; 312(5770):111-4. PubMed ID: 16601193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme Efficiency but Not Thermostability Drives Cefotaxime Resistance Evolution in TEM-1 β-Lactamase.
    Knies JL; Cai F; Weinreich DM
    Mol Biol Evol; 2017 May; 34(5):1040-1054. PubMed ID: 28087769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.
    Guthrie VB; Allen J; Camps M; Karchin R
    PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational spectrum drives the rise of mutator bacteria.
    Couce A; Guelfo JR; Blázquez J
    PLoS Genet; 2013; 9(1):e1003167. PubMed ID: 23326242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of a multilocus mutator genotype in mutator Escherichia coli experimental populations under repeated lethal selection.
    Elgrail MM; Sprouffske K; Dartey JO; Garcia AM
    J Evol Biol; 2024 Mar; 37(3):346-352. PubMed ID: 38367184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic evolution of antibiotic resistance is contingent on genetic background following a long-term experiment with
    Card KJ; Thomas MD; Graves JL; Barrick JE; Lenski RE
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33441451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal Interference and Mutation Bias in Small Bacterial Populations in Droplets.
    Ruelens P; de Visser JAGM
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33557200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation supply and the repeatability of selection for antibiotic resistance.
    van Dijk T; Hwang S; Krug J; de Visser JAGM; Zwart MP
    Phys Biol; 2017 Aug; 14(5):055005. PubMed ID: 28699625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli mutators: selection criteria and migration effect.
    Le Chat L; Fons M; Taddei F
    Microbiology (Reading); 2006 Jan; 152(Pt 1):67-73. PubMed ID: 16385116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of β-Lactam Resistance Pathway Depends Critically on Initial Antibiotic Concentration.
    Ruelens P; de Visser JAGM
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0047121. PubMed ID: 33972257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutators can drive the evolution of multi-resistance to antibiotics.
    Gifford DR; Berríos-Caro E; Joerres C; Suñé M; Forsyth JH; Bhattacharyya A; Galla T; Knight CG
    PLoS Genet; 2023 Jun; 19(6):e1010791. PubMed ID: 37311005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
    Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
    PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capturing the mutational landscape of the beta-lactamase TEM-1.
    Jacquier H; Birgy A; Le Nagard H; Mechulam Y; Schmitt E; Glodt J; Bercot B; Petit E; Poulain J; Barnaud G; Gros PA; Tenaillon O
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13067-72. PubMed ID: 23878237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene.
    Schenk MF; Szendro IG; Salverda ML; Krug J; de Visser JA
    Mol Biol Evol; 2013 Aug; 30(8):1779-87. PubMed ID: 23676768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.